A detailed history of Brandywine Global Investment Management, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 92,585 shares of DGX stock, worth $12.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
92,585
Previous 88,549 4.56%
Holding current value
$12.7 Million
Previous $12.1 Million 4.72%
% of portfolio
0.09%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$137.09 - $137.09 $553,295 - $553,295
4,036 Added 4.56%
92,585 $12.7 Million
Q2 2024

Aug 14, 2024

BUY
$125.91 - $144.34 $402,408 - $461,310
3,196 Added 3.74%
88,549 $12.1 Million
Q1 2024

May 13, 2024

SELL
$123.78 - $142.11 $43,075 - $49,454
-348 Reduced 0.41%
85,353 $11.4 Million
Q4 2023

Feb 09, 2024

SELL
$120.62 - $141.12 $20.3 Million - $23.7 Million
-168,263 Reduced 66.25%
85,701 $11.8 Million
Q3 2023

Nov 13, 2023

SELL
$121.86 - $144.92 $1.22 Million - $1.45 Million
-10,005 Reduced 3.79%
253,964 $30.9 Million
Q2 2023

Aug 11, 2023

SELL
$130.56 - $146.84 $1.13 Million - $1.27 Million
-8,643 Reduced 3.17%
263,969 $37.1 Million
Q1 2023

May 12, 2023

SELL
$131.53 - $155.76 $984,765 - $1.17 Million
-7,487 Reduced 2.67%
272,612 $38.6 Million
Q4 2022

Feb 10, 2023

BUY
$123.31 - $157.26 $8.8 Million - $11.2 Million
71,377 Added 34.2%
280,099 $43.8 Million
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $13 Million - $15 Million
-106,540 Reduced 33.79%
208,722 $25.6 Million
Q2 2022

Aug 11, 2022

BUY
$127.07 - $145.39 $3.54 Million - $4.05 Million
27,851 Added 9.69%
315,262 $41.9 Million
Q1 2022

May 13, 2022

BUY
$129.09 - $164.35 $2.23 Million - $2.84 Million
17,296 Added 6.4%
287,411 $39.3 Million
Q4 2021

Feb 11, 2022

BUY
$140.36 - $173.01 $11.5 Million - $14.1 Million
81,723 Added 43.38%
270,115 $46.7 Million
Q3 2021

Nov 12, 2021

BUY
$132.95 - $158.0 $5.35 Million - $6.36 Million
40,264 Added 27.18%
188,392 $27.4 Million
Q2 2021

Aug 13, 2021

SELL
$126.66 - $141.48 $773,512 - $864,018
-6,107 Reduced 3.96%
148,128 $19.5 Million
Q1 2021

May 13, 2021

BUY
$114.63 - $133.34 $4.73 Million - $5.5 Million
41,277 Added 36.54%
154,235 $19.8 Million
Q4 2020

Feb 10, 2021

BUY
$112.7 - $128.05 $24,794 - $28,171
220 Added 0.2%
112,958 $13.5 Million
Q3 2020

Nov 12, 2020

SELL
$107.05 - $130.01 $447,683 - $543,701
-4,182 Reduced 3.58%
112,738 $12.9 Million
Q2 2020

Aug 14, 2020

SELL
$73.34 - $122.61 $43,783 - $73,198
-597 Reduced 0.51%
116,920 $13.3 Million
Q1 2020

May 15, 2020

SELL
$75.14 - $115.68 $146,372 - $225,344
-1,948 Reduced 1.63%
117,517 $9.44 Million
Q4 2019

Feb 14, 2020

BUY
$100.29 - $107.99 $142,812 - $153,777
1,424 Added 1.21%
119,465 $12.6 Million
Q3 2019

Nov 14, 2019

BUY
$97.85 - $107.42 $259,791 - $285,200
2,655 Added 2.3%
118,041 $12.6 Million
Q2 2019

Aug 14, 2019

BUY
$85.18 - $101.94 $381,180 - $456,181
4,475 Added 4.03%
115,386 $11.7 Million
Q1 2019

May 15, 2019

SELL
$80.68 - $89.92 $194,035 - $216,257
-2,405 Reduced 2.12%
110,911 $9.97 Million
Q4 2018

Feb 14, 2019

SELL
$79.75 - $108.38 $79,750 - $108,380
-1,000 Reduced 0.87%
113,316 $9.44 Million
Q3 2018

Nov 14, 2018

SELL
$105.42 - $114.99 $386,469 - $421,553
-3,666 Reduced 3.11%
114,316 $12.3 Million
Q2 2018

Aug 14, 2018

SELL
$97.35 - $113.14 $267,907 - $311,361
-2,752 Reduced 2.28%
117,982 $13 Million
Q1 2018

May 15, 2018

BUY
$96.42 - $107.88 $48,499 - $54,263
503 Added 0.42%
120,734 $12.1 Million
Q4 2017

Feb 14, 2018

BUY
$90.86 - $100.24 $325,278 - $358,859
3,580 Added 3.07%
120,231 $11.8 Million
Q3 2017

Nov 14, 2017

SELL
$91.96 - $108.35 $4.62 Million - $5.44 Million
-50,229 Reduced 30.1%
116,651 $10.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
166,880
166,880 $18.6 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.